Clinical Status: AOD-9604 is a synthetic peptide analog evaluated in multiple human and animal studies for obesity and cartilage repair research
If it is, it is likely to become available first to those who need it most and will be subject to strict eligibility criteria
IGF-1 has growth-stimulating effects on a wide variety of tissues
Moderate to Severe Deficiency: For moderate to severe deficiencies, the dosage may increase to 1,000 mcg several times a week initially, followed by a maintenance dose
Nasseris personalized guidance, you can enjoy a treatment plan that supports lasting energy and wellnesshelping you feel more focused, refreshed, and ready to take on whatever the day brings
Amazing results which continue to be noticeable and are far above my expectations